Dr Reddys Laboratories receives EIR for facility at Duvvada

Dr Reddys Laboratories has received the Establishment Inspection Report (EIR) from USFDA, for the company's formulations manufacturing facility at Duvvada, Visakhapatnam (Vizag SEZ Plant 1- FTO 7), indicating closure of the audit. As intimated earlier the facility has been classified as V AI (Voluntary Action Indicated).

Powered by Capital Market - Live News